Nephrogenic Systemic Fibrosis (NSF) & Blood Vessel Angioplasty Lawyer

Tweet

Although the exact cause of Nephrogenic Systemic Fibrosis (NSF) is still unknown, case studies have revealed that recent surgeries -particularly blood vessel angioplasties and other vascular surgeries – have occurred prior to the onset of NSF in a high number of patients.

Free NSF Case Evaluation: If you or a loved one has developed Nephrogenic Systemic Fibrosis (NSF) after undergoing a blood vessel angioplasty or other vascular surgery, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What is Nephrogenic Systemic Fibrosis (NSF)?

Nephrogenic systemic fibrosis (NSF) is a systemic disorder affecting the skin, as well as the body’s connective tissues. NSF has been linked to gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging (MRI) procedures, including a form of MRI called magnetic resonance angiography (MRA) — an imaging scan used by doctors to distinguish blood vessels from surrounding tissues. Thus far, NSF has only been reported in patients with kidney disorders.

What Causes NSF?

NSF has been closely associated with blood vessel angioplasty procedures, as well as a number of other conditions and events including:

• Thrombosis
• Coagulation issues
• AV Fistula
• Failed kidney transplant
• Sudden onset of kidney disease characterized by swelling of the extremities

Researchers are currently investigating to see if any of these events could be a trigger for NSF. It is important to note that many of these events are preceded or followed by MRI or MRA exams. So the common denominator linking these events to the development of NSF may just be the gadolinium-based contrast dyes used with the MRI and MRA exams.

Do I have a Nephrogenic Systemic Fibrosis (NSF) Lawsuit?

The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Nephrogenic Systemic Fibrosis (NSF) lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.